ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$12.82 +0.73%
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.65M
Average 1.06M
ADRX Total Debt
Short-term and long-term borrowings combined.
No reported Total Debt figures are available to summarize.
Total Debt history
Currency unavailable · from the balance sheet
No Total Debt data reported for this period type.
Total Debt vs competitors
How ADRX compares with its peers on the latest reported figures
ADRX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $114.51M USD | -5.5% | +59.4% | 38.9% | |
| Mar 2026 | $87.53M USD | +8.2% | -1.3% | 35.8% | |
| Mar 2026 | $23.99M USD | -43.8% | -35.9% | 9.8% | |
| Mar 2026 | $15.72M USD | -33.4% | -22.1% | 2.7% | |
| Mar 2026 | €13.7M EUR | -16.0% | -14.0% | 13.8% | |
| Mar 2026 | $3.42M USD | +45.6% | +8.4% | 0.8% | |
| Mar 2026 | $2.68M USD | — | — | 0.9% | |
| Mar 2026 | $876K USD | -8.7% | +1.5% | 0.5% | |
| Mar 2026 | $136K USD | +126.7% | -28.9% | 0.1% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -7.1% | -7.6% | 2.7% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.